OLN324: Why Size May Matter - Poll - MDSpire

OLN324: Why Size May Matter

David A. Eichenbaum, MD, FASRS, and Veeral S. Sheth, MD, MBA, discuss phase 1 JADE findings and how OLN324's small-format design may contribute to improved retinal drying in nAMD and diabetic macular edema.

  • By

  • David A. Eichenbaum, MD

  • Veeral S. Sheth, MD, MBA, FACS

  • July 15, 2026

  • 3 min

Share

Original Source(s)

OLN324: Why Size May Matter

  • by David A. Eichenbaum, MD, Veeral S. Sheth, MD, MBA, FACS

  • July 15, 2026

Related Content

Drs. Berrocal Reflect on ASRS 2026

ASRS 2026 meeting program chair Audina M. “Nina” Berrocal, MD, FASRS, joins Maria H. Berrocal, MD, to discuss the meeting’s highlights, surgical sessions, and educational approach.

Expanding Optogenetics to Geographic Atrophy

Jordi Monés, MD, PhD, discusses the rationale for evaluating MCO-010 (sonpiretigene isteparvovec) in GA following encouraging findings in retinitis pigmentosa and Stargardt disease.

Neuroprotection: Retina's Next Frontier?

At OIS Retina in Montreal, Riad Sherif, MD, discussed Oculis’s optic neuritis program and why neuroprotection may represent the next frontier in retinal therapeutics.